Pharmx Technologies Ltd (PHX) - Cash Flow Conversion Efficiency

Latest as of December 2024: -0.552x

Based on the latest financial reports, Pharmx Technologies Ltd (PHX) has a cash flow conversion efficiency ratio of -0.552x as of December 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-8.91 Million ≈ $-6.30 Million USD) by net assets (AU$16.15 Million ≈ $11.43 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is Pharmx Technologies Ltd worth for the company's overall valuation and market capitalisation.

Pharmx Technologies Ltd - Cash Flow Conversion Efficiency Trend (2007–2024)

This chart illustrates how Pharmx Technologies Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Pharmx Technologies Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Pharmx Technologies Ltd ranked by their cash flow conversion efficiency. Explore PHX cash flow quality score to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
PJP Makrum S.A.
WAR:PJP
-0.062x
InspireMD Inc
NASDAQ:NSPR
-0.265x
XPLUS SA ZY -01
F:75R
0.168x
Tracxn Technologies Limited
NSE:TRACXN
0.019x
Mas Murni Indonesia Tbk
JK:MAMI
0.000x
Usio Inc
NASDAQ:USIO
0.016x
Bumyang Construction Co Ltd
KO:002410
1.569x
MicroCloud Hologram Inc.
NASDAQ:HOLO
0.003x

Annual Cash Flow Conversion Efficiency for Pharmx Technologies Ltd (2007–2024)

The table below shows the annual cash flow conversion efficiency of Pharmx Technologies Ltd from 2007 to 2024. View PHX live share price for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-06-30 AU$15.97 Million
≈ $11.30 Million
AU$3.21 Million
≈ $2.27 Million
0.201x -59.28%
2023-06-30 AU$22.21 Million
≈ $15.72 Million
AU$10.94 Million
≈ $7.74 Million
0.493x +421.33%
2022-06-30 AU$23.20 Million
≈ $16.42 Million
AU$2.19 Million
≈ $1.55 Million
0.095x -31.46%
2021-06-30 AU$22.93 Million
≈ $16.22 Million
AU$3.16 Million
≈ $2.24 Million
0.138x +393.18%
2020-06-30 AU$13.20 Million
≈ $9.34 Million
AU$369.00K
≈ $261.09K
0.028x -79.21%
2019-06-30 AU$10.02 Million
≈ $7.09 Million
AU$1.35 Million
≈ $953.80K
0.135x +476.38%
2018-06-30 AU$14.23 Million
≈ $10.07 Million
AU$332.00K
≈ $234.91K
0.023x +30.98%
2017-06-30 AU$13.98 Million
≈ $9.89 Million
AU$249.00K
≈ $176.18K
0.018x +127.93%
2016-06-30 AU$19.91 Million
≈ $14.09 Million
AU$-1.27 Million
≈ $-898.61K
-0.064x -135.99%
2015-06-30 AU$19.93 Million
≈ $14.10 Million
AU$3.53 Million
≈ $2.50 Million
0.177x -41.07%
2014-06-30 AU$18.87 Million
≈ $13.35 Million
AU$5.68 Million
≈ $4.02 Million
0.301x -25.59%
2013-06-30 AU$16.36 Million
≈ $11.57 Million
AU$6.61 Million
≈ $4.68 Million
0.404x -7.53%
2012-06-30 AU$10.68 Million
≈ $7.55 Million
AU$4.67 Million
≈ $3.30 Million
0.437x -44.72%
2011-06-30 AU$4.65 Million
≈ $3.29 Million
AU$3.67 Million
≈ $2.60 Million
0.791x +1.31%
2010-06-30 AU$2.90 Million
≈ $2.05 Million
AU$2.26 Million
≈ $1.60 Million
0.780x -10.54%
2008-06-30 AU$5.11 Million
≈ $3.61 Million
AU$4.46 Million
≈ $3.15 Million
0.872x +148.45%
2007-06-30 AU$7.55 Million
≈ $5.34 Million
AU$2.65 Million
≈ $1.88 Million
0.351x --

About Pharmx Technologies Ltd

AU:PHX Australia Health Information Services
Market Cap
$36.06 Million
AU$50.96 Million AUD
Market Cap Rank
#23214 Global
#868 in Australia
Share Price
AU$0.09
Change (1 day)
-3.41%
52-Week Range
AU$0.08 - AU$0.17
All Time High
AU$0.17
About

PharmX Technologies Limited, together with its subsidiaries, operates as a technology and software development company in Australia. It also operates PharmX, an electronic ordering and invoicing gateway; PharmX Marketplace, an e-commerce ordering platform; PharmX Analytics which provides insights for operations of supplier and pharmacy customers. The company was formerly known as Corum Group Limi… Read more